William H. Lyness

2.2k total citations
51 papers, 1.8k citations indexed

About

William H. Lyness is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, William H. Lyness has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in William H. Lyness's work include Neurotransmitter Receptor Influence on Behavior (24 papers), Neuroscience and Neuropharmacology Research (16 papers) and Diabetes Management and Research (7 papers). William H. Lyness is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (24 papers), Neuroscience and Neuropharmacology Research (16 papers) and Diabetes Management and Research (7 papers). William H. Lyness collaborates with scholars based in United States, Denmark and United Kingdom. William H. Lyness's co-authors include Kenneth E. Moore, N.M. Friedle, Arthur P. Leccese, Forrest L. Smith, Sherwyn Schwartz, Randall L. Commissaris, Richard H. Rech, Richard E. Sievers, Thomas E. Tenner and Sasanka Ramanadham and has published in prestigious journals such as Neurology, Diabetes Care and Brain Research.

In The Last Decade

William H. Lyness

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by William H. Lyness

Since Specialization

Citations

This map shows the geographic impact of William H. Lyness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Lyness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Lyness more than expected).

Fields of papers citing papers by William H. Lyness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Lyness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Lyness. The network helps show where William H. Lyness may publish in the future.

Co-authorship network of co-authors of William H. Lyness

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Lyness. A scholar is included among the top collaborators of William H. Lyness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Lyness. William H. Lyness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Twice‐daily dosing of a repaglinide/metformin fixed‐dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet 2009 ·Diabetes Obesity and Metabolism ·Philip Raskin, Alex Lewin, Richard Reinhardt, William H. Lyness, (unknown)	11
2	Twice‐daily and three‐times‐daily dosing of a repaglinide/metformin fixed‐dose combination tablet provide similar glycaemic control 2009 ·Diabetes Obesity and Metabolism ·Philip Raskin, Alex Lewin, Richard Reinhardt, William H. Lyness, (unknown)	6
3	Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin 2008 ·Clinical Drug Investigation ·David Hoelscher, Pei-Ling Chu, William H. Lyness	8
4	Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment 2005 ·British Journal of Clinical Pharmacology ·Gregory B. Holmes, Lawrence Galitz, Peter Hu, William H. Lyness	61
5	Similarity of Insulin Detemir Pharmacokinetics, Safety, and Tolerability Profiles in Healthy Caucasian and Japanese American Subjects 2004 ·The Journal of Clinical Pharmacology ·S. S. Jhee, William H. Lyness, (unknown), Mark Leibowitz, Victoria Zarotsky, Lisbeth V. Jacobsen	18
6	A multicenter, open-label, randomized, two-period crossovertrial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitus 2004 ·Clinical Therapeutics ·Sherwyn Schwartz, David Hassman, J J Shelmet, Richard E. Sievers, Richard L. Weinstein, John Z. Liang, William H. Lyness	75
7	Preference and resource utilization in elderly patients: InnoLet® versus vial/syringe 2003 ·Diabetes Research and Clinical Practice ·J J Shelmet, Sherwyn Schwartz, (unknown), Gregory M. Peterson, Søren Skovlund, (unknown), L Nicklasson, John Z. Liang, William H. Lyness	58
8	Coadministration of Phenytoin and Felbamate: Evidence of Additional Phenytoin Dose‐Reduction Requirements Based on Pharmacokinetics and Tolerability with Increasing Doses of Felbamate 1999 ·Epilepsia ·Rajesh Sachdeo, Mary Wagner, (unknown), Robert Shumaker, William H. Lyness, A. Rosenberg, (unknown), James L. Perhach	12
9	Evaluation of the Potential Interaction Between Felbamate and Erythromycin in Patients with Epilepsy 1998 ·The Journal of Clinical Pharmacology ·Rǎjesh C. Sachdeo, (unknown), (unknown), Robert Shumaker, James L. Perhach, William H. Lyness, A. Rosenberg	6
10	Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers 1997 ·The Journal of Clinical Pharmacology ·Joel Morganroth, William H. Lyness, James L. Perhach, Gary Mather, (unknown), W. Trager, René H. Levy, A. Rosenberg	12
11	Tolerability and Pharmacokinetics of Monotherapy Felbamate Doses of 1,200–6,000 mg/day in Subjects with Epilepsy 1997 ·Epilepsia ·Rajesh Sachdeo, (unknown), Robert Shumaker, James L. Perhach, William H. Lyness, A. Rosenberg	13
12	Influence of dopaminergic and serotonergic neurons on intravenous ethanol self-administration in the rat 1992 ·Pharmacology Biochemistry and Behavior ·William H. Lyness, Forrest L. Smith	66
13	Morphine self-administration in the rat during adjuvant-induced arthritis 1989 ·Life Sciences ·William H. Lyness, Forrest L. Smith, James E. Heavner, (unknown), (unknown)	55
14	Lesions of dopamine neurons in the medial prefrontal cortex: Effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat 1987 ·Neuropharmacology ·Arthur P. Leccese, William H. Lyness	66
15	Potentiation of barbiturate hypnosis by probenecid: Differential effect in tolerant animals, 1981 ·Neuropharmacology ·William H. Lyness	4
16	Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Randall L. Commissaris, William H. Lyness, Kenneth E. Moore, Richard H. Rech	18
17	Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats 1981 ·Pharmacology Biochemistry and Behavior ·Randall L. Commissaris, William H. Lyness, Kenneth E. Moore, Richard H. Rech	37
18	II. Measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in discrete brain nuclei using reverse phase liquid chromatography with electrochemical detection 1980 ·Life Sciences ·William H. Lyness, N.M. Friedle, K E Moore	34
19	Cross-tolerance to centrally injected barbiturates 1979 ·European Journal of Pharmacology ·William H. Lyness, Henry E. Brezenoff, Mary J. Mycek	8
20	Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration 1979 ·Pharmacology Biochemistry and Behavior ·William H. Lyness, N.M. Friedle, Kenneth E. Moore	373

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact